Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Shtalrid

Showing results (51-60 of 62) with videos related to

Pageof 7
Sort By:
Leukemia|December 1, 1994
Verapamil inhibits B-cell proliferation and tumor necrosis factor release and induces a clinical response in B-cell chronic lymphocytic leukemiaA Berrebi, M Shtalrid, A Klepfish, et al.
Blood|August 1, 1988
Analysis of breakpoints within the bcr gene and their correlation with the clinical course of Philadelphia-positive chronic myelogenous leukemiaM Shtalrid, M Talpaz, R Kurzrock, et al.
British Journal of Haematology|September 1, 1987
Molecular analysis of chromosome 22 breakpoints in adult Philadelphia-positive acute lymphoblastic leukaemiaR Kurzrock, M Shtalrid, J U Gutterman, et al.
Cancer Genetics and Cytogenetics|August 1, 1987
Molecular characteristics of chronic myelogenous leukemia in blast crisisM Blick, P Romero, M Talpaz, et al.
Cancer Research|July 15, 1988
Multiple restriction fragment length polymorphisms of the human epidermal growth factor receptor geneJ S Lee, J S Ro, A Eisbruch, et al.
Blood|January 1, 1990
Rearrangement and expression of p53 in the chronic phase and blast crisis of chronic myelogenous leukemiaR Mashal, M Shtalrid, M Talpaz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1988
Philadelphia-negative chronic myelogenous leukemia with breakpoint cluster region rearrangement: molecular analysis, clinical characteristics, and response to therapyM Shtalrid, M Talpaz, M Blick, et al.
Nature|February 12, 1987
A novel c-abl protein product in Philadelphia-positive acute lymphoblastic leukaemiaR Kurzrock, M Shtalrid, P Romero, et al.
Israel Journal of Medical Sciences|October 1, 1995
Interferon-alpha-2b with VMCP for induction in multiple myeloma: the Israel Myeloma Cooperative Group experienceA M Cohen, D Meytes, A Many, et al.
Cancer Research|December 22, 1999
Autologous T cells control B-chronic lymphocytic leukemia tumor progression in human-->mouse radiation chimeraA Shimoni, H Marcus, B Dekel, et al.
Pageof 7

Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
Leukemia|December 1, 1994
Verapamil inhibits B-cell proliferation and tumor necrosis factor release and induces a clinical response in B-cell chronic lymphocytic leukemiaA Berrebi, M Shtalrid, A Klepfish, et al.
Blood|August 1, 1988
Analysis of breakpoints within the bcr gene and their correlation with the clinical course of Philadelphia-positive chronic myelogenous leukemiaM Shtalrid, M Talpaz, R Kurzrock, et al.
British Journal of Haematology|September 1, 1987
Molecular analysis of chromosome 22 breakpoints in adult Philadelphia-positive acute lymphoblastic leukaemiaR Kurzrock, M Shtalrid, J U Gutterman, et al.
Cancer Genetics and Cytogenetics|August 1, 1987
Molecular characteristics of chronic myelogenous leukemia in blast crisisM Blick, P Romero, M Talpaz, et al.
Cancer Research|July 15, 1988
Multiple restriction fragment length polymorphisms of the human epidermal growth factor receptor geneJ S Lee, J S Ro, A Eisbruch, et al.
Blood|January 1, 1990
Rearrangement and expression of p53 in the chronic phase and blast crisis of chronic myelogenous leukemiaR Mashal, M Shtalrid, M Talpaz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1988
Philadelphia-negative chronic myelogenous leukemia with breakpoint cluster region rearrangement: molecular analysis, clinical characteristics, and response to therapyM Shtalrid, M Talpaz, M Blick, et al.
Nature|February 12, 1987
A novel c-abl protein product in Philadelphia-positive acute lymphoblastic leukaemiaR Kurzrock, M Shtalrid, P Romero, et al.
Israel Journal of Medical Sciences|October 1, 1995
Interferon-alpha-2b with VMCP for induction in multiple myeloma: the Israel Myeloma Cooperative Group experienceA M Cohen, D Meytes, A Many, et al.
Cancer Research|December 22, 1999
Autologous T cells control B-chronic lymphocytic leukemia tumor progression in human-->mouse radiation chimeraA Shimoni, H Marcus, B Dekel, et al.
Pageof 7